Carlos Arteaga, M.D.
The University of Texas Southwestern Medical Center
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR170061|
Recruitment of Established Investigators
Vanderbilt University School of Medicine
August 16, 2017
Breast cancer can often be cured with a combination of surgery, hormonal therapy, chemotherapy, and radiation. But some breast cancers are resistant to treatment from the outset, or develop drug resistance over time.
Dr. Carlos L. Arteaga, M.D., an internationally renowned breast cancer researcher and physician, is hoping to improve breast-cancer patients’ chances of beating the disease for good. His research focuses on identifying the causes of drug resistance and employing combination therapies to circumvent it.
Dr. Arteaga was recruited to the University of Texas Southwestern Medical Center, with the help of a CPRIT Established Investigator Award, as Director of the Harold C. Simmons Comprehensive Cancer Center. Previously, he spent 28 years at Vanderbilt University Medical Center, where he was the director of the Center for Cancer Targeted Therapies (C2T2) and the Breast Cancer Program of the Vanderbilt-Ingram Cancer Center.